Report period | 2020 | 2021 | 2022 | 2023 | 2024 | Q1 25 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
MCK:US | McKesson Corporation | Common share | - | US58155Q1031 | $552.2 |
Company name | McKesson |
---|---|
Tags | #s&p500 index |
Sector | Health Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Distributors |
Business address | ONE POST ST MCKESSON PLAZA SAN FRANCISCO CA 94104 4159838300 |
Mailing address | ONE POST ST SAN FRANCISCO CA 94104 |
Website | investor.mckesson.com |
Information disclosure | www.sec.gov |